R&D
Beyond our two commercial verticals, Greenverse is advancing a pipeline of technologies drawn from more than twenty years of engineering research.
Cryochemical Drying (CCD) for blood plasma preservation. Stores plasma for up to 10 years without the frozen cold chain, with clotting-factor levels at or above fresh frozen plasma after reconstitution. Being developed for technology transfer and commercialisation with industry partners.
Non-invasive diagnostic devices for different organs, extending the platform behind the brain diagnostic programme. Combines oscillatory, vibrational and acoustic signal capture with patient-specific digital twins and a human-computer interface for real-time clinical decision support.
Gas-dynamic separation system for recovering helium and other noble gases from natural gas and industrial gas streams. Currently at feasibility stage, with study scope and investor materials prepared.
Investors, operators, port authorities, clinical partners or press — tell us your enquiry type and we will route it from Westminster.
